VIM and neoplasm: These findings were corroborated by the IHC analysis, performed in an external cohort collected at the Technical University of Munich, which identified vimentin in the epithelial tumor region of TNBC, while in the luminal and HER2+ subtypes, vimentin was solely present in the stroma.